Compare
5 stocks, side by sideRelative performance · rebased to 100
NAMSCRNXTLXRCUSRLAY
| NAMSNewAmsterdam Pharma Company N.V. | CRNXCrinetics Pharmaceuticals, Inc. | TLXTelix Pharmaceuticals Limited | RCUSArcus Biosciences, Inc. | RLAYRelay Therapeutics, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 3/10 | 4/10 | - | 8/10 | 9/10 |
| Price | $31.73 | $34.99 | $10.86 | $30.25 | $17.83 |
| 1 month | -12% | -4.9% | +13% | +25% | +26% |
| 1 year | +72% | +13% | -34% | +246% | +439% |
| 5 year | +225% | +81% | - | +27% | -49% |
| P/E (TTM) | -17.4 | -7.4 | - | -10.3 | -14.2 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $3.7B | $3.7B | $3.7B | $3.8B | $3.9B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.